Szilassy, Eszter
Coope, Caroline
Emsley, Elizabeth
Williamson, Emma
Barbosa, Estela Capelas
Johnson, Medina
Dowrick, Anna
Feder, Gene
Funding for this research was provided by:
National Institute for Health and Care Research (RP-PG-0614-20012, RP-PG-0614-20012, RP-PG-0614-20012, RP-PG-0614-20012, RP-PG-0614-20012, RP-PG-0614-20012, RP-PG-0614-20012, RP-PG-0614-20012)
Article History
Received: 10 May 2023
Accepted: 15 December 2023
First Online: 26 January 2024
Declarations
:
: The study was given favourable ethical approval by London—Hampstead Research Ethics Committee (REC reference: 19/LO/1132) and the Health Research Authority (HRA) and Health and Care Research Wales (HCRW).Participants were sent a copy of the participant information sheet and consent form in advance, had the opportunity to discuss the study and answer questions prior to consenting to participate. All participants gave written informed consent or audio-recorded verbal informed consent to take part in the study.The study was conducted in accordance with the relevant guidelines, regulations and ethical approvals.
: Not applicable.
: EW is a regional manager for IRISi interventions since May 2022. ECB worked part-time as a data scientist for IRISi between June 2019 and March 2022 responsible for collecting and analysing IRIS data at national level. MJ is the CEO of IRISi and was a named partner in REPROVIDE. Feder is a non-executive (unpaid) IRISi board member. All other authors have declared no competing interests.